4 Results for "

Rovalpituzumab

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Rovalpituzumab" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P99043
CAS No.: 1613313-01-1
Synonyms: SC-0001

Target:  

Notch

Research Areas:  

Cancer

Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC) .
loading...
    loading...
Cat. No.: HY-132257
CAS No.: 1613313-09-9
Synonyms: SC-002
Research Areas:  

Cancer

Rovalpituzumab tesirine (SC-002) is an antibody-drug conjugate (ADC) with anticancer effects. Rovalpituzumab tesirine contains a DLL3-targeting antibody Rovalpituzumab (HY-P99043) tethered to a cytotoxic agent pyrrolobenzodiazepine by means of a protease-cleavable linker. Rovalpituzumab tesirine can be used for the stduy of small cell lung cancer (SCLC) .
loading...
    loading...
Cat. No.: HY-159072
CAS No.: 2575682-08-3
Purity:  96.22%
Research Areas:  

Cancer

Mal-Val-Ala-PAB-N(SO2Me)-Exatecan (Compound LE14) is a conjugate of an ADC toxin Exatecan (HY-13631) and a linker Mal-Val-Ala-PAB-N(SO2Me). Mal-Val-Ala-PAB-N(SO2Me)-Exatecan can be used for synthesis of ADC FZ-AD005. FZ-AD005 is a delta-like ligand 3 (DLL3, KD=58.3 pM) targeting ADC, that exhibits antitumor efficacy against SCLC cancer .
loading...
    loading...
Cat. No.: HY-159072A
Mal-Val-Ala-PAB-N(SO2Me)-Exatecan TFA is a conjugate of an ADC toxin Exatecan (HY-13631) and a linker Mal-Val-Ala-PAB-N(SO2Me). Mal-Val-Ala-PAB-N(SO2Me)-Exatecan TFA can be used for synthesis of ADC FZ-AD005. FZ-AD005 is a delta-like ligand 3 (DLL3, KD=58.3 pM) targeting ADC, that exhibits antitumor efficacy against SCLC cancer .
loading...
    loading...